Nii-Kono T - Search Results

1

Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism.

Nishi H, Nii-Kono T, Nakanishi S, Yamazaki Y, Yamashita T, Fukumoto S, Ikeda K, Fujimori A, Fukagawa M. Nishi H, et al. Nephron Clin Pract. 2005;101(2):c94-9. doi: 10.1159/000086347. Epub 2005 Jun 14. Nephron Clin Pract. 2005. PMID: 15956805

2

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

Nakanishi S, Kazama JJ, Nii-Kono T, Omori K, Yamashita T, Fukumoto S, Gejyo F, Shigematsu T, Fukagawa M. Nakanishi S, et al. Kidney Int. 2005 Mar;67(3):1171-8. doi: 10.1111/j.1523-1755.2005.00184.x. Kidney Int. 2005. PMID: 15698459 Free article.

3

Role of fibroblast growth factor 23 in health and in chronic kidney disease.

Fukagawa M, Nii-Kono T, Kazama JJ. Fukagawa M, et al. Curr Opin Nephrol Hypertens. 2005 Jul;14(4):325-9. doi: 10.1097/01.mnh.0000172717.49476.80. Curr Opin Nephrol Hypertens. 2005. PMID: 15930999 Review.

4

No change in circulating osteoprotegerin levels by intravenous calcitriol therapy among dialysis patients with secondary hyperparathyroidism.

Nishi H, Nii-Kono T, Ikeda K, Fujimori A, Fukagawa M. Nishi H, et al. Among authors: nii kono t. Clin Nephrol. 2006 Feb;65(2):149-50. doi: 10.5414/cnp65149. Clin Nephrol. 2006. PMID: 16509469 No abstract available.

5

Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients.

Koiwa F, Kazama JJ, Tokumoto A, Onoda N, Kato H, Okada T, Nii-Kono T, Fukagawa M, Shigematsu T; ROD21 Clinical Research Group. Koiwa F, et al. Among authors: nii kono t. Ther Apher Dial. 2005 Aug;9(4):336-9. doi: 10.1111/j.1744-9987.2005.00293.x. Ther Apher Dial. 2005. PMID: 16076378 Clinical Trial.

6

Serum pro-hepcidin as an indicator of iron status in dialysis patients.

Tsuchihashi D, Abe T, Komaba H, Fujii H, Hamada Y, Nii-Kono T, Tanaka M, Fukagawa M. Tsuchihashi D, et al. Among authors: nii kono t. Ther Apher Dial. 2008 Jun;12(3):226-31. doi: 10.1111/j.1744-9987.2008.00578.x. Ther Apher Dial. 2008. PMID: 18503700

7

Direct injection of calcitriol or its analog improves abnormal gene expression in the hyperplastic parathyroid gland in uremia.

Shiizaki K, Fukagawa M, Yuan Q, Hatamura I, Nii-Kono T, Saji F, Shigematsu T, Akizawa T. Shiizaki K, et al. Among authors: nii kono t. Am J Nephrol. 2008;28(1):59-66. doi: 10.1159/000109240. Epub 2007 Sep 28. Am J Nephrol. 2008. PMID: 17901691

8

Insufficiency of PTH action on bone in uremia.

Iwasaki Y, Yamato H, Nii-Kono T, Fujieda A, Uchida M, Hosokawa A, Motojima M, Fukagawa M. Iwasaki Y, et al. Among authors: nii kono t. Kidney Int Suppl. 2006 Jul;(102):S34-6. doi: 10.1038/sj.ki.5001600. Kidney Int Suppl. 2006. PMID: 16810309 Free article. Review.

9

Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone.

Iwasaki-Ishizuka Y, Yamato H, Nii-Kono T, Kurokawa K, Fukagawa M. Iwasaki-Ishizuka Y, et al. Among authors: nii kono t. Nephrol Dial Transplant. 2005 Sep;20(9):1904-11. doi: 10.1093/ndt/gfh876. Epub 2005 Jun 28. Nephrol Dial Transplant. 2005. PMID: 15985520

10

Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells.

Nii-Kono T, Iwasaki Y, Uchida M, Fujieda A, Hosokawa A, Motojima M, Yamato H, Kurokawa K, Fukagawa M. Nii-Kono T, et al. Kidney Int. 2007 Apr;71(8):738-43. doi: 10.1038/sj.ki.5002097. Epub 2007 Jan 31. Kidney Int. 2007. PMID: 17264878 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters